Form 4 for QNCX Quince Therapeutics, Inc.
Accepted 2021-08-18 00:00:00 ET · period of report 2021-08-16 · accession 0001209191-21-052285 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-18 | 2021-08-16 | QNCX | McLoughlin Margaret | Dir | S - Sale+OE | $95.44 | -6,000 | 0 | -100% | -$572.6K |
| D | 2021-08-18 | 2021-08-16 | QNCX | McLoughlin Margaret | Dir | M - OptEx | $17.00 | +6,000 | 6,000 | New | +$102.0K |
| D | 2021-08-18 | 2021-08-16 | QNCX | McLoughlin Margaret | Dir | M - OptEx | $0.00 | -6,000 | 85.9K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-16 | S | D | 423 | $97.55 | 48 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.22 to $97.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 2 | Common | Common Stock | 2021-08-16 | S | D | 1,429 | $96.51 | 471 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.12 to $97.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 3 | Common | Common Stock | 2021-08-16 | S | D | 1,044 | $95.57 | 1,900 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.07 to $96.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 4 | Common | Common Stock | 2021-08-16 | S | D | 3,056 | $94.55 | 2,944 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.06 to $95.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 5 | Common | Common Stock | 2021-08-16 | M | A | 6,000 | $17.00 | 6,000 | D | — | — | |
| 6 | Common | Common Stock | 2021-08-16 | S | D | 48 | $98.90 | 0 | D | — | — | |
| 7 | Derivative | Stock Option (right to buy) | 2021-08-16 | M | D | 6,000 | $0.00 | 85,911 | D | $17.00 · — to 2029-05-07 | 6,000 Common Stock | (F6) The option vested as to 1/3rd of the shares on May 8, 2020, with the remaining 2/3rd of shares vesting in equal monthly installments beginning on June 8, 2020 and ending on May 8, 2022. |